| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.45 | 3e-24 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.38 | 0.002 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.3 | 6e-16 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.3 | 4e-10 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.29 | 2e-12 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.29 | 8e-12 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.29 | 0.003 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.29 | 2e-18 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.29 | 6e-15 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.28 | 6e-10 |